Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Instituto Peruano de Biologia Molecular was a Peru-based private company organized as a Sociedad Anonima Cerrada and appears to have operated in molecular biology and related professional scientific services. Public business-directory records identify the company under the abbreviation IPBM and list its economic activity in broad professional, scientific, and technical services rather than as a drug developer with a disclosed therapeutic pipeline. Available records indicate the company was founded in 2006 and later marked with definitive deregistration or closure status in Peru. No evidence was found of marketed therapeutics, clinical-stage assets, or a proprietary drug platform.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Instituto Peruano de Biologia Molecular.